cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients

dc.contributor.author	Turnes Vázquez, Juan
dc.date.accessioned	2017-06-07T07:04:14Z
dc.date.available	2017-06-07T07:04:14Z
dc.date.issued	2013
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2234
dc.language.iso	eng
dc.title	cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients
dc.type	Publicación de congreso
dc.authorsophos	Turnes, J.
dc.authorsophos	Oyaguez, I.
dc.authorsophos	Planas, R.
dc.authorsophos	Garcia-Samaniego, J.
dc.authorsophos	Diago, M.
dc.authorsophos	Crespo, J.
dc.authorsophos	Calleja, J. L.
dc.authorsophos	Sola, R.
dc.authorsophos	Casado, M. A.
dc.authorsophos	Romero-Gomez, M.
dc.identifier.isi	330252205221
dc.identifier.sophos	12791
dc.issue.number	SUPPL. 1
dc.journal.title	Hepatology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Dixestivo
dc.page.initial	1107A
dc.page.final	1108A
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	58

Files in this item

Files	Size	Format	View
There are no files associated with this item.